Rivastigmine in the Treatment of Postoperative Delirium: a Pilot Clinical Trial

Clinical trial NCT00835159 · COMPLETED

Trial details

NCT number: NCT00835159
Sponsor: NYU Langone Health
Status: COMPLETED
Phase: Phase 4
Study type: INTERVENTIONAL

Delirium Postoperative Cognitive Dysfunction

Start date: 2008-12-01
Primary completion: 2010-07-01
Enrollment: 30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.